Prospects for the prevention of dementia

被引:8
作者
Jorm, Anthony F. [1 ]
机构
[1] Australian Natl Univ, Mental Hlth Res Ctr, Canberra, ACT 0200, Australia
关键词
D O I
10.1111/j.1741-6612.2002.tb00408.x
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Prevention of diseases can involve either: (a) their elimination from the lifespan of the individual, or (6) their postponement until later in the lifespan. The elimination of Alzheimer's disease or vascular dementia is not likely in the near future, although ongoing trials of vaccination against Alzheimer's pathology offer some prospects. Postponement of dementia remains a more likely scenario. Possible ways of postponing Alzheimer's disease include medications such as anti-inflammatory drugs, oestrogen and antioxidants; and possibly the reduction of occupational risk factors like electromagnetic fields and medical risk factors like head trauma. For vascular dementia, there are lifestyle changes and medications like antihypertensives, antiplatelet drugs, folate and cholesterol lowering drugs. Prevention of dementia is sometimes justified on the basis that it will save government money. However, the situation is complex and in some circumstances, prevention may actually lead to an increase in costs to government.
引用
收藏
页码:9 / 13
页数:5
相关论文
共 32 条
  • [1] COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS
    ALTMAN, R
    CARRERAS, L
    DIAZ, R
    FIGUEROA, E
    PAOLASSO, E
    PARODI, JC
    CADE, JF
    DONNAN, G
    EADIE, MJ
    GAVAGHAN, TP
    OSULLIVAN, EF
    PARKIN, D
    RENNY, JTG
    SILAGY, C
    VINAZZER, H
    ZEKERT, F
    ADRIAENSEN, H
    BERTRANDHARDY, JM
    BRAN, M
    DAVID, JL
    DRICOT, J
    LAVENNEPARDONGE, E
    LIMET, R
    LOWENTHAL, A
    MORIAU, M
    SCHAPIRA, S
    SMETS, P
    SYMOENS, J
    VERHAEGHE, R
    VERSTRAETE, M
    ATALLAH, A
    BARNETT, H
    BATISTA, R
    BLAKELY, J
    CAIRNS, JA
    COTE, R
    CROUCH, J
    EVANS, G
    FINDLAY, JM
    GENT, M
    LANGLOIS, Y
    LECLERC, J
    NORRIS, J
    PINEO, GF
    POWERS, PJ
    ROBERTS, R
    SCHWARTZ, L
    SICURELLA, J
    TAYLOR, W
    THEROUX, P
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 1994, 308 (6921): : 81 - 100
  • [2] Preventing fatal diseases increases healthcare costs: cause elimination life table approach
    Bonneux, L
    Barendregt, JJ
    Nusselder, WJ
    Van der Maas, PJ
    [J]. BRITISH MEDICAL JOURNAL, 1998, 316 (7124) : 26 - 29
  • [3] Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset
    Brookmeyer, R
    Gray, S
    Kawas, C
    [J]. AMERICAN JOURNAL OF PUBLIC HEALTH, 1998, 88 (09) : 1337 - 1342
  • [4] Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease
    Clarke, R
    Smith, AD
    Jobst, KA
    Refsum, H
    Sutton, L
    Ueland, PM
    [J]. ARCHIVES OF NEUROLOGY, 1998, 55 (11) : 1449 - 1455
  • [5] Dementia and occupational exposure to magnetic fields
    Feychting, M
    Pedersen, NL
    Svedberg, P
    Floderus, B
    Gatz, M
    [J]. SCANDINAVIAN JOURNAL OF WORK ENVIRONMENT & HEALTH, 1998, 24 (01) : 46 - 53
  • [6] Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial
    Forette, F
    Seux, ML
    Staessen, JA
    Thijs, L
    Birkenhäger, WH
    Babarskiene, MR
    Babeanu, S
    Bossini, A
    Gil-Extremera, B
    Girerd, X
    Laks, T
    Lilov, E
    Moisseyev, V
    Tuomilehto, J
    Vanhanen, H
    Webster, J
    Yodfat, Y
    Fagard, R
    [J]. LANCET, 1998, 352 (9137) : 1347 - 1351
  • [7] Cholesterol lowering with statin drugs, risk of stroke, and total mortality - An overview of randomized trials
    Hebert, PR
    Gaziano, JM
    Chan, KS
    Hennekens, CH
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 278 (04): : 313 - 321
  • [8] Estrogen for Alzheimer's disease in women - Randomized, double-blind, placebo-controlled trial
    Henderson, VW
    Paganini-Hill, A
    Miller, BL
    Elble, RJ
    Reyes, PF
    Shoupe, D
    McCleary, CA
    Klein, RA
    Hake, AM
    Farlow, MR
    [J]. NEUROLOGY, 2000, 54 (02) : 295 - 301
  • [9] Statins and the risk of dementia
    Jick, H
    Zornberg, GL
    Jick, SS
    Seshadri, S
    Drachman, DA
    [J]. LANCET, 2000, 356 (9242) : 1627 - 1631
  • [10] Kalmijn S, 1997, AM J EPIDEMIOL, V145, P33, DOI 10.1093/oxfordjournals.aje.a009029